According to Ocular Therapeutix's latest financial reports the company has โฌ0.40 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | โฌ0.17 B | 85.73% |
2022-12-31 | โฌ95.36 M | -34.21% |
2021-12-31 | โฌ0.14 B | -21.82% |
2020-12-31 | โฌ0.18 B | 281.55% |
2019-12-31 | โฌ48.59 M | 2.83% |
2018-12-31 | โฌ47.25 M | 36.51% |
2017-12-31 | โฌ34.61 M | -46.56% |
2016-12-31 | โฌ64.78 M | -32.58% |
2015-12-31 | โฌ96.08 M | 56.18% |
2014-12-31 | โฌ61.52 M | 385.39% |
2013-12-31 | โฌ12.67 M | -29.71% |
2012-12-31 | โฌ18.03 M |